New Treatments in Chronic Liver Disease 2025

New Treatments in Chronic Liver Disease 2025

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

  • Provider:Scripps Health
  • Activity Link: https://www.scripps.org/events/new-treatments-in-chronic-liver-disease-2025-march-15-2025
  • Start Date: 2025-03-15 05:00:00
  • End Date: 2025-03-15 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 8.75 hours
  • MOC Credit Details: ABPATH - 8.75 Point; Credit Type(s): Lifelong Learning (ABPATH)
    ABIM - 8.75 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: No
  • Activity Type: Live Course
  • CME Finder Type: Conference
  • Fee to Participate: Yes
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Clinical Pathology, Gastroenterology, GI (incl. Liver, Pancreas, Bilary), Infectious Disease, Infectious Diseases/Medical Microbiology, Internal Medicine, Transplant Hepatology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.